ArticleInfectious diseases and therapy2024

Clinical Outcome and 7-Day Virological Clearance in High-Risk Patients with Mild-Moderate COVID-19 Treated with Molnupiravir, Nirmatrelvir/Ritonavir, or Remdesivir.

Francesca Bai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.